Literature DB >> 1884604

Lifetime prevalence of psychiatric disorders in patients with alopecia areata.

E A Colón1, M K Popkin, A L Callies, N J Dessert, M K Hordinsky.   

Abstract

Thirty-one patients with alopecia areata were administered a structured psychiatric interview (the Diagnostic Interview Schedule; DIS). Overall, 74% had one or more lifetime psychiatric diagnoses. Particularly noteworthy were the high lifetime prevalence rates of major depression (39%) and generalized anxiety disorder (39%). In addition, patients reported increased rates of psychiatric disorders in first-degree relatives: anxiety disorders (58%), affective disorders (35%), and substance use disorders (35%). Patients with patchy alopecia areata were more likely to have a diagnosis of generalized anxiety disorder. No relationships were found between major depression and any variable characterizing alopecia areata history. Possible interrelationships between psychiatric disorders and alopecia areata are discussed. The study suggests that patients with alopecia areata are at increased risk for psychiatric disorders, and calls attention to the need for psychiatric assessment in this population.

Entities:  

Mesh:

Year:  1991        PMID: 1884604     DOI: 10.1016/0010-440x(91)90045-e

Source DB:  PubMed          Journal:  Compr Psychiatry        ISSN: 0010-440X            Impact factor:   3.735


  17 in total

Review 1.  Review of quality of life studies in women with alopecia.

Authors:  D S Davis; V D Callender
Journal:  Int J Womens Dermatol       Date:  2018-01-09

2.  Autoimmune hair loss (alopecia areata) transferred by T lymphocytes to human scalp explants on SCID mice.

Authors:  A Gilhar; Y Ullmann; T Berkutzki; B Assy; R S Kalish
Journal:  J Clin Invest       Date:  1998-01-01       Impact factor: 14.808

3.  Psychodermatology: a guide to understanding common psychocutaneous disorders.

Authors:  Mohammad Jafferany
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2007

4.  Psychosocial and psychiatric comorbidities and health-related quality of life in alopecia areata: A systematic review.

Authors:  Atrin Toussi; Virginia R Barton; Stephanie T Le; Oma N Agbai; Maija Kiuru
Journal:  J Am Acad Dermatol       Date:  2020-06-17       Impact factor: 15.487

Review 5.  Recent advances in the pathogenesis of autoimmune hair loss disease alopecia areata.

Authors:  Taisuke Ito
Journal:  Clin Dev Immunol       Date:  2013-09-18

Review 6.  A review of psychiatric disorders comorbidities in patients with alopecia areata.

Authors:  Ahmad Ghanizadeh; Anaheed Ayoobzadehshirazi
Journal:  Int J Trichology       Date:  2014-01

7.  Successful treatment of corticosteroid-resistant ophiasis-type alopecia areata (AA) with platelet-rich plasma (PRP).

Authors:  Jeff Donovan
Journal:  JAAD Case Rep       Date:  2015-08-25

8.  Psychiatric evaluation in dermatology: an overview.

Authors:  Sreyoshi Ghosh; Rishikesh V Behere; Psvn Sharma; K Sreejayan
Journal:  Indian J Dermatol       Date:  2013-01       Impact factor: 1.494

Review 9.  Epidemiology and burden of alopecia areata: a systematic review.

Authors:  Alexandra C Villasante Fricke; Mariya Miteva
Journal:  Clin Cosmet Investig Dermatol       Date:  2015-07-24

10.  Psychiatric morbidity and quality of life in skin diseases: A comparison of alopecia areata and psoriasis.

Authors:  Sagar B Karia; Avinash De Sousa; Nilesh Shah; Sushma Sonavane; Anup Bharati
Journal:  Ind Psychiatry J       Date:  2015 Jul-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.